Medtrum today unveiled the 300-unit version of its TouchCare Nano tubeless automated insulin delivery patch pump.

"The Pivot submission is an exciting milestone in our mission to deliver a differentiated tubeless patch pump experience to those who want a simple pump to manage the treatment of diabetes," commented ...

Please provide your email address to receive an email when new articles are posted on . The Accu-Chek Solo micropump (Roche Diabetes) was granted 510(k) clearance from the FDA. According to the ...

Ottawa, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The global tubeless insulin pump market size is projected to surpass USD 13.65 billion by 2034, increasing from USD 3.48 billion in 2026, growing at a strong ...

The Omnipod 5 will be immediately available for people ages 6 to 70. A new technology for people with Type 1 diabetes, one that has been nearly a decade in the making, has been approved by the U.S.

Insulet Corporation (NASDAQ: PODD) ("Insulet" or the "Company"), the global leader in tubeless insulin pump technology with ...

Medtrum’s latest advances center on its ultra-compact tubeless insulin pumps. The 200U configuration measures just 40.5 × 31.5 × 11.5 mm and weighs only 13.8 grams, making it the smallest and lightest ...

The Industry growth report "Tubeless Insulin Pump MarketBy Component (Pod/Patch, Remote, Others), By Distribution Channel (Hospitals, Pharmacies, e-Commerce, Others ...

The global Tubeless Insulin Pump market size was valued at USD 594.53 million in 2022 and is expected to expand at a CAGR of 18.6 percentage during the forecast period, reaching USD 1654.2 million by ...

Submission delayed by U.S. government shutdown; initial FDA questions expected during Q4 2025 "The Pivot submission is an exciting milestone in our mission to deliver a differentiated tubeless patch ...